 | • レポートコード：D0804-14112 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、減量薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。減量薬の種類別市場規模（液体、錠剤）、用途別市場規模（減量剤、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Lunan Pharmaceutical Group Corporation、Sandoz(Novartis)、GSK group、National Company For Pharmaceutical Industry、Teva、Hisun、Hexal AG、STADA-VN J.V.Co., Ltd、Zein Pharmaceutical、Taj Pharmaceuticals Ltd、China Zhongshan Pharm、Kabir Life Sciences & Research、Dm Pharma ・地域別グローバル市場分析 2015年-2020年 ・減量薬の北米市場（アメリカ、カナダ、メキシコ） ・減量薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・減量薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・減量薬の南米市場（ブラジル、アルゼンチン） ・減量薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：液体、錠剤 ・用途別分析：減量剤、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Weight Loss Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Weight Loss Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Weight Loss Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Weight Loss Drugs market has been segmented into
Liauid
Tablets
By Application, Weight Loss Drugs has been segmented into:
Weight-reducing Aid
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Weight Loss Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Weight Loss Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Weight Loss Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Weight Loss Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Weight Loss Drugs Market Share Analysis
Weight Loss Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Weight Loss Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Weight Loss Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Weight Loss Drugs are:
Roche
Lunan Pharmaceutical Group Corporation
Sandoz(Novartis)
GSK group
National Company For Pharmaceutical Industry
Teva
Hisun
Hexal AG
STADA-VN J.V.Co., Ltd
Zein Pharmaceutical
Taj Pharmaceuticals Ltd
China Zhongshan Pharm
Kabir Life Sciences & Research
Dm Pharma
Among other players domestic and global, Weight Loss Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Weight Loss Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Weight Loss Drugs, with price, sales, revenue and global market share of Weight Loss Drugs in 2018 and 2019.
Chapter 3, the Weight Loss Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Weight Loss Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Weight Loss Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Weight Loss Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Weight Loss Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Weight Loss Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Liauid
1.2.3 Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Weight Loss Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Weight-reducing Aid
1.3.3 Other
1.4 Overview of Global Weight Loss Drugs Market
1.4.1 Global Weight Loss Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lunan Pharmaceutical Group Corporation
2.2.1 Lunan Pharmaceutical Group Corporation Details
2.2.2 Lunan Pharmaceutical Group Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lunan Pharmaceutical Group Corporation SWOT Analysis
2.2.4 Lunan Pharmaceutical Group Corporation Product and Services
2.2.5 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sandoz(Novartis)
2.3.1 Sandoz(Novartis) Details
2.3.2 Sandoz(Novartis) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sandoz(Novartis) SWOT Analysis
2.3.4 Sandoz(Novartis) Product and Services
2.3.5 Sandoz(Novartis) Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK group
2.4.1 GSK group Details
2.4.2 GSK group Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK group SWOT Analysis
2.4.4 GSK group Product and Services
2.4.5 GSK group Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 National Company For Pharmaceutical Industry
2.5.1 National Company For Pharmaceutical Industry Details
2.5.2 National Company For Pharmaceutical Industry Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 National Company For Pharmaceutical Industry SWOT Analysis
2.5.4 National Company For Pharmaceutical Industry Product and Services
2.5.5 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva SWOT Analysis
2.6.4 Teva Product and Services
2.6.5 Teva Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hisun
2.7.1 Hisun Details
2.7.2 Hisun Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hisun SWOT Analysis
2.7.4 Hisun Product and Services
2.7.5 Hisun Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Hexal AG
2.8.1 Hexal AG Details
2.8.2 Hexal AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Hexal AG SWOT Analysis
2.8.4 Hexal AG Product and Services
2.8.5 Hexal AG Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 STADA-VN J.V.Co., Ltd
2.9.1 STADA-VN J.V.Co., Ltd Details
2.9.2 STADA-VN J.V.Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 STADA-VN J.V.Co., Ltd SWOT Analysis
2.9.4 STADA-VN J.V.Co., Ltd Product and Services
2.9.5 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Zein Pharmaceutical
2.10.1 Zein Pharmaceutical Details
2.10.2 Zein Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Zein Pharmaceutical SWOT Analysis
2.10.4 Zein Pharmaceutical Product and Services
2.10.5 Zein Pharmaceutical Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Taj Pharmaceuticals Ltd
2.11.1 Taj Pharmaceuticals Ltd Details
2.11.2 Taj Pharmaceuticals Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Taj Pharmaceuticals Ltd SWOT Analysis
2.11.4 Taj Pharmaceuticals Ltd Product and Services
2.11.5 Taj Pharmaceuticals Ltd Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 China Zhongshan Pharm
2.12.1 China Zhongshan Pharm Details
2.12.2 China Zhongshan Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 China Zhongshan Pharm SWOT Analysis
2.12.4 China Zhongshan Pharm Product and Services
2.12.5 China Zhongshan Pharm Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Kabir Life Sciences & Research
2.13.1 Kabir Life Sciences & Research Details
2.13.2 Kabir Life Sciences & Research Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Kabir Life Sciences & Research SWOT Analysis
2.13.4 Kabir Life Sciences & Research Product and Services
2.13.5 Kabir Life Sciences & Research Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Dm Pharma
2.14.1 Dm Pharma Details
2.14.2 Dm Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Dm Pharma SWOT Analysis
2.14.4 Dm Pharma Product and Services
2.14.5 Dm Pharma Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Weight Loss Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Weight Loss Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Weight Loss Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Weight Loss Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Weight Loss Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Weight Loss Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Weight Loss Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Weight Loss Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Weight Loss Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Weight Loss Drugs Sales and Growth Rate (2015-2020)
4.5 South America Weight Loss Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Weight Loss Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Weight Loss Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Weight Loss Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Weight Loss Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Weight Loss Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Weight Loss Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Weight Loss Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Weight Loss Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Weight Loss Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Weight Loss Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Weight Loss Drugs Sales and Growth Rate (2015-2020)
6.3 UK Weight Loss Drugs Sales and Growth Rate (2015-2020)
6.4 France Weight Loss Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Weight Loss Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Weight Loss Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Weight Loss Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Weight Loss Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Weight Loss Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Weight Loss Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Weight Loss Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Weight Loss Drugs Sales and Growth Rate (2015-2020)
7.5 India Weight Loss Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Weight Loss Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Weight Loss Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Weight Loss Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Weight Loss Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Weight Loss Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Weight Loss Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Weight Loss Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Weight Loss Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Weight Loss Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Weight Loss Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Weight Loss Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Weight Loss Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Weight Loss Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Weight Loss Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Weight Loss Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Weight Loss Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Weight Loss Drugs Price by Type (2015-2020)
11 Global Weight Loss Drugs Market Segment by Application
11.1 Global Weight Loss Drugs Sales Market Share by Application (2015-2020)
11.2 Global Weight Loss Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Weight Loss Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Weight Loss Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Weight Loss Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Weight Loss Drugs Market Forecast (2021-2025)
12.2.2 Europe Weight Loss Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Weight Loss Drugs Market Forecast (2021-2025)
12.2.4 South America Weight Loss Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Weight Loss Drugs Market Forecast (2021-2025)
12.3 Weight Loss Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Weight Loss Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Weight Loss Drugs Market Share Forecast by Type (2021-2025)
12.4 Weight Loss Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Weight Loss Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Weight Loss Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Weight Loss Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Weight Loss Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Weight Loss Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Weight Loss Drugs Major Business
Table 9. Roche Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Roche SWOT Analysis
Table 11. Roche Weight Loss Drugs Product and Services
Table 12. Roche Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Lunan Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Major Business
Table 15. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 16. Lunan Pharmaceutical Group Corporation SWOT Analysis
Table 17. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Product and Services
Table 18. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sandoz(Novartis) Basic Information, Manufacturing Base and Competitors
Table 20. Sandoz(Novartis) Weight Loss Drugs Major Business
Table 21. Sandoz(Novartis) Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Sandoz(Novartis) SWOT Analysis
Table 23. Sandoz(Novartis) Weight Loss Drugs Product and Services
Table 24. Sandoz(Novartis) Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GSK group Basic Information, Manufacturing Base and Competitors
Table 26. GSK group Weight Loss Drugs Major Business
Table 27. GSK group Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 28. GSK group SWOT Analysis
Table 29. GSK group Weight Loss Drugs Product and Services
Table 30. GSK group Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. National Company For Pharmaceutical Industry Basic Information, Manufacturing Base and Competitors
Table 32. National Company For Pharmaceutical Industry Weight Loss Drugs Major Business
Table 33. National Company For Pharmaceutical Industry Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 34. National Company For Pharmaceutical Industry SWOT Analysis
Table 35. National Company For Pharmaceutical Industry Weight Loss Drugs Product and Services
Table 36. National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Basic Information, Manufacturing Base and Competitors
Table 38. Teva Weight Loss Drugs Major Business
Table 39. Teva Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 40. Teva SWOT Analysis
Table 41. Teva Weight Loss Drugs Product and Services
Table 42. Teva Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Hisun Basic Information, Manufacturing Base and Competitors
Table 44. Hisun Weight Loss Drugs Major Business
Table 45. Hisun Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Hisun SWOT Analysis
Table 47. Hisun Weight Loss Drugs Product and Services
Table 48. Hisun Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Hexal AG Basic Information, Manufacturing Base and Competitors
Table 50. Hexal AG Weight Loss Drugs Major Business
Table 51. Hexal AG Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 52. Hexal AG SWOT Analysis
Table 53. Hexal AG Weight Loss Drugs Product and Services
Table 54. Hexal AG Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. STADA-VN J.V.Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 56. STADA-VN J.V.Co., Ltd Weight Loss Drugs Major Business
Table 57. STADA-VN J.V.Co., Ltd Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 58. STADA-VN J.V.Co., Ltd SWOT Analysis
Table 59. STADA-VN J.V.Co., Ltd Weight Loss Drugs Product and Services
Table 60. STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Zein Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Zein Pharmaceutical Weight Loss Drugs Major Business
Table 63. Zein Pharmaceutical Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 64. Zein Pharmaceutical SWOT Analysis
Table 65. Zein Pharmaceutical Weight Loss Drugs Product and Services
Table 66. Zein Pharmaceutical Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Taj Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Taj Pharmaceuticals Ltd Weight Loss Drugs Major Business
Table 69. Taj Pharmaceuticals Ltd Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 70. Taj Pharmaceuticals Ltd SWOT Analysis
Table 71. Taj Pharmaceuticals Ltd Weight Loss Drugs Product and Services
Table 72. Taj Pharmaceuticals Ltd Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. China Zhongshan Pharm Basic Information, Manufacturing Base and Competitors
Table 74. China Zhongshan Pharm Weight Loss Drugs Major Business
Table 75. China Zhongshan Pharm Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 76. China Zhongshan Pharm SWOT Analysis
Table 77. China Zhongshan Pharm Weight Loss Drugs Product and Services
Table 78. China Zhongshan Pharm Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Kabir Life Sciences & Research Basic Information, Manufacturing Base and Competitors
Table 80. Kabir Life Sciences & Research Weight Loss Drugs Major Business
Table 81. Kabir Life Sciences & Research Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 82. Kabir Life Sciences & Research SWOT Analysis
Table 83. Kabir Life Sciences & Research Weight Loss Drugs Product and Services
Table 84. Kabir Life Sciences & Research Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Dm Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Dm Pharma Weight Loss Drugs Major Business
Table 87. Dm Pharma Weight Loss Drugs Total Revenue (USD Million) (2018-2019)
Table 88. Dm Pharma SWOT Analysis
Table 89. Dm Pharma Weight Loss Drugs Product and Services
Table 90. Dm Pharma Weight Loss Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Weight Loss Drugs Sales by Manufacturer (2018-2019) (K Tablets)
Table 92. Global Weight Loss Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Weight Loss Drugs Sales by Regions (2015-2020) (K Tablets)
Table 94. Global Weight Loss Drugs Sales Market Share by Regions (2015-2020)
Table 95. Global Weight Loss Drugs Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Weight Loss Drugs Sales by Countries (2015-2020) (K Tablets)
Table 97. North America Weight Loss Drugs Sales Market Share by Countries (2015-2020)
Table 98. North America Weight Loss Drugs Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Weight Loss Drugs Revenue Market Share by Countries (2015-2020)
Table 100. Europe Weight Loss Drugs Sales by Countries (2015-2020) (K Tablets)
Table 101. Europe Weight Loss Drugs Sales Market Share by Countries (2015-2020)
Table 102. Europe Weight Loss Drugs Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Weight Loss Drugs Sales by Regions (2015-2020) (K Tablets)
Table 104. Asia-Pacific Weight Loss Drugs Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Weight Loss Drugs Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Weight Loss Drugs Sales by Countries (2015-2020) (K Tablets)
Table 107. South America Weight Loss Drugs Sales Market Share by Countries (2015-2020)
Table 108. South America Weight Loss Drugs Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Weight Loss Drugs Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Weight Loss Drugs Sales by Countries (2015-2020) (K Tablets)
Table 111. Middle East & Africa Weight Loss Drugs Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Weight Loss Drugs Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Weight Loss Drugs Revenue Market Share by Countries (2015-2020)
Table 114. Global Weight Loss Drugs Sales by Type (2015-2020) (K Tablets)
Table 115. Global Weight Loss Drugs Sales Share by Type (2015-2020)
Table 116. Global Weight Loss Drugs Revenue by Type (2015-2020) (USD Million)
Table 117. Global Weight Loss Drugs Revenue Share by Type (2015-2020)
Table 118. Global Weight Loss Drugs Sales by Application (2015-2020) (K Tablets)
Table 119. Global Weight Loss Drugs Sales Share by Application (2015-2020)
Table 120. Global Weight Loss Drugs Sales Forecast by Regions (2021-2025) (K Tablets)
Table 121. Global Weight Loss Drugs Market Share Forecast by Regions (2021-2025)
Table 122. Global Weight Loss Drugs Sales Forecast by Type (2021-2025) (K Tablets)
Table 123. Global Weight Loss Drugs Market Share Forecast by Type (2021-2025)
Table 124. Global Weight Loss Drugs Sales Forecast by Application (2021-2025)
Table 125. Global Weight Loss Drugs Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Weight Loss Drugs Picture
Figure 2. Global Sales Market Share of Weight Loss Drugs by Type in 2019
Figure 3. Liauid Picture
Figure 4. Tablets Picture
Figure 5. Weight Loss Drugs Sales Market Share by Application in 2018
Figure 6. Weight-reducing Aid Picture
Figure 7. Other Picture
Figure 8. Global Weight Loss Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Weight Loss Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Weight Loss Drugs Sales Market Share by Manufacturer in 2019
Figure 29. Global Weight Loss Drugs Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Weight Loss Drugs Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Weight Loss Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 34. Global Weight Loss Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Weight Loss Drugs Revenue Market Share by Regions (2015-2020)
Figure 36. Global Weight Loss Drugs Revenue Market Share by Regions in 2018
Figure 37. North America Weight Loss Drugs Sales and Growth Rate (2015-2020)
Figure 38. Europe Weight Loss Drugs Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Weight Loss Drugs Sales and Growth Rate (2015-2020)
Figure 40. South America Weight Loss Drugs Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Weight Loss Drugs Sales and Growth Rate (2015-2020)
Figure 42. North America Weight Loss Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Weight Loss Drugs Sales Market Share by Countries (2015-2020)
Figure 44. North America Weight Loss Drugs Sales Market Share by Countries in 2018
Figure 45. North America Weight Loss Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Weight Loss Drugs Revenue Market Share by Countries in 2018
Figure 47. United States Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 48. Canada Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 49. Mexico Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 50. Europe Weight Loss Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Weight Loss Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Weight Loss Drugs Revenue Market Share by Countries in 2019
Figure 53. Germany Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 54. UK Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 55. France Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 56. Russia Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 57. Italy Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 58. Asia-Pacific Weight Loss Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Weight Loss Drugs Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Weight Loss Drugs Revenue Market Share by Regions 2019
Figure 61. China Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 62. Japan Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 63. Korea Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 64. India Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 65. Southeast Asia Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 66. South America Weight Loss Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Weight Loss Drugs Sales Market Share by Countries in 2019
Figure 68. South America Weight Loss Drugs Revenue Market Share by Countries in 2019
Figure 69. Brazil Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 70. Argentina Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 71. Middle East and Africa Weight Loss Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Weight Loss Drugs Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Weight Loss Drugs Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Weight Loss Drugs Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 76. Egypt Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 77. Turkey Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 78. South Africa Weight Loss Drugs Sales and Growth Rate (2015-2020) (K Tablets)
Figure 79. Global Weight Loss Drugs Sales and Growth Rate (2021-2025) (K Tablets)
Figure 80. Global Weight Loss Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Weight Loss Drugs Market Forecast (2021-2025) (K Tablets)
Figure 82. Europe Sales Weight Loss Drugs Market Forecast (2021-2025) (K Tablets)
Figure 83. Asia-Pacific Sales Weight Loss Drugs Market Forecast (2021-2025) (K Tablets)
Figure 84. South America Sales Weight Loss Drugs Market Forecast (2021-2025) (K Tablets)
Figure 85. Middle East & Africa Sales Weight Loss Drugs Market Forecast (2021-2025) (K Tablets)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
減量用食事置換シェイクの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Meal Replacement Shakes for Weight Loss market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…- ウェイトベルトの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Weight Belts market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Weight Belts market report provi…
- 中分子量ポリイソブチレンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Medium Molecular Weight Polyisobutylene market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…
- 重量ラベリングマシンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Weight Labelling Machines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Weight Labelling Ma…
- 医療用超高分子量ポリエチレン（UHMWPE）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Medical Grade Ultra-High Molecular Weight Polyethylene (UHMWPE) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mi…